The City Hospital of Ostrava is seeking suppliers for the provision of Voriconazole, an antifungal medication in injectable form (200mg). The expected consumption over the next four years is 2,392 units. This contract is valued at approximately €3,302,457.39 and is part of the health sector. Interes
Contract awarded. Originally published 1 years ago.
No single supplier dominates the field.
In healthcare medical, OSTRAVA CITY HOSPITAL CONTRIBUTORY ORGANIZATION has awarded 4 contracts to 4 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This public procurement contract involves the ongoing supply of materials for incontinence and absorption, based on the current needs of the contracting authority. The supplies will be delivered over a period of 36 months from the effective date of the contract. The contract is valued at approximate
This public contract involves the commitment of the provider to ensure the delivery of goods and services related to health, sports, culture, social development (referred to as 'benefits'), and catering through an electronic system commonly known as Cafeteria (referred to as 'E-system'). Benefits wi
This contract involves the supply of medical equipment for a robotic surgery room. It includes ongoing deliveries of consumable materials and a comprehensive post-warranty service package, which also covers the supply of spare parts, for an indefinite period.
This public procurement contract involves the ongoing supply of specialized medical materials necessary for the treatment of patients with aneurysm conditions in the Radiology and Imaging Methods department. The contract will last for 36 months from the effective date. The goods supplied must meet t
UK Home Office seeks a global tuberculosis screening service provider to manage visa applicant testing across international locations through various delivery models.
Norfolk County Council is seeking a contractor to provide technology-enabled and virtual care services that help residents maintain independence and improve outcomes while remaining in their own homes.
Market engagement RFI for integrated criminal justice liaison, prison reentry and mental health treatment services across Lancashire and Cumbria, closing 4 September 2026.
UKHSA is seeking supplier participation in a market engagement exercise for Pralidoxime Chloride supply in 2026 through a formal Request for Information process.
